The rising impact of biomarkers in early clinical development
Drug Target Review
APRIL 7, 2025
The parallel evolution of novel therapies, biomarker endpoints and regulatory evolution may signal a new paradigm for clinical drug development over the coming years. Silver Spring (MD): Food and Drug Administration (US); 2016-. Clinical Pharmacology and Therapeutics. Clinical Pharmacology and Therapeutics.
Let's personalize your content